Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ · Healthcare
Recursion Pharmaceuticals, Inc. Gross Margin 2019–2025
Current and historical gross margin for Recursion Pharmaceuticals, Inc. (RXRX) over the last 10 years. The current gross profit margin for Recursion Pharmaceuticals, Inc. as of December 31, 2025 is 4.99%.
From: 12/31/2019To: 12/31/2025
Revenue
Gross Profit
Gross Margin
Recursion Pharmaceuticals, Inc. Gross Margin — FAQ
Recursion Pharmaceuticals, Inc. (RXRX) gross margin over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Recursion Pharmaceuticals, Inc.'s gross margin?
Recursion Pharmaceuticals, Inc. (RXRX) reported gross margin of 5.0% for fiscal 2025.
Where can I see RXRX's gross margin history?
The chart and table above show Recursion Pharmaceuticals, Inc.'s gross margin by year and by quarter, including the growth rate.